Adolor Corporation to Host Investor Conference Call to Discuss Results of Phase 2 Trials of ADL5945 in OIC
August 09 2011 - 4:01PM
Business Wire
Adolor Corporation (NasdaqGM: ADLR) today announced that it will
hold a conference call at 8:30 a.m. EDT on Wednesday, August 10,
2011, to discuss the results of its Phase 2 trials of ADL5945 in
chronic opioid-induced constipation (OIC).
To participate in the audio portion and have the opportunity to
pose questions, dial 866-202-3109 for domestic callers or
617-213-8844 for international callers, and enter Conference ID #
62949696. Investors also can listen to the call live and view a
slide presentation by logging on to the Company’s website at
www.adolor.com and clicking on “Investor Insights,” then "Calendar
of Events."
A replay of the call will be available beginning approximately
two hours after the event. To listen to a replay of the conference
call, dial 888-286-8010 (domestic) or 617-801-6888 (international)
and enter Conference ID # 75827916 or listen via Adolor’s website.
The replay will be available for one week.
About Adolor
Adolor Corporation is a biopharmaceutical company specializing
in the discovery, development and commercialization of novel
prescription pain and pain management products.
Adolor’s first approved product in the United States is ENTEREG®
(alvimopan), which is indicated to accelerate the time to upper and
lower gastrointestinal recovery following partial large or small
bowel resection surgery with primary anastomosis. ENTEREG is
available for short-term use in hospitals registered under the
E.A.S.E.® Program. For more information on ENTEREG, including its
full prescribing information, visit www.ENTEREG.com. The Company
currently co-promotes ENTEREG in collaboration with GSK.
The Company's research and development pipeline includes:
ADL5945 and ADL7445, novel mu opioid receptor antagonists
undergoing clinical development for chronic OIC; and several
earlier-stage compounds under development for the management of
pain and CNS disorders.
For more information, visit www.adolor.com.
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jul 2023 to Jul 2024